Gliclazide: A Comprehensive Drug Profile

What is Gliclazide?

Gliclazide is an oral antidiabetic medication belonging to the sulfonylurea class of drugs. It is primarily prescribed to help control blood sugar levels in people with type 2 diabetes mellitus. This medication works by stimulating the pancreas to produce more insulin, helping to lower elevated blood glucose levels when diet and exercise alone are insufficient.

Uses

Gliclazide is approved and commonly used for several diabetes-related conditions:

• Type 2 diabetes mellitus: The primary indication for managing blood glucose levels in patients whose condition cannot be controlled through diet and exercise alone
• Combination therapy: Often used alongside other antidiabetic medications such as metformin when single-drug therapy is inadequate
• Post-meal glucose control: Particularly effective at reducing blood sugar spikes after eating due to its insulin-stimulating action
• Long-term diabetes management: Used as part of comprehensive diabetes care to help prevent complications associated with poorly controlled blood sugar
• Transition therapy: Sometimes prescribed when patients need to switch from other diabetes medications due to intolerance or inadequate response

How it works

Gliclazide works by binding to specific receptors on the beta cells in the pancreas, which are responsible for producing insulin. This binding action closes potassium channels in the cell membrane, leading to calcium influx and subsequent release of insulin into the bloodstream. The increased insulin helps cells throughout the body absorb glucose more effectively, thereby lowering blood sugar levels.

Side effects

Common side effects include:

Submit Your Paper

• Hypoglycemia (low blood sugar)
• Weight gain
• Nausea and stomach upset
• Headache
• Dizziness
• Skin rash or allergic reactions
• Diarrhea
• Fatigue or weakness

Serious side effects requiring immediate medical attention:

• Severe hypoglycemia with confusion, seizures, or loss of consciousness
• Severe allergic reactions including difficulty breathing or swelling of face and throat
• Signs of liver problems such as yellowing of skin or eyes
• Blood disorders including unusual bruising or bleeding
• Severe skin reactions including blistering or peeling

Warnings and precautions

• Kidney and liver impairment: Patients with severe kidney or liver disease should use gliclazide with extreme caution or avoid it entirely, as the drug’s clearance may be significantly reduced
• Pregnancy and breastfeeding: Generally not recommended during pregnancy as insulin is preferred for diabetes management in pregnant women; consult healthcare provider about breastfeeding safety
• Elderly patients: Increased risk of hypoglycemia due to age-related changes in kidney function and medication metabolism
• G6PD deficiency: Patients with glucose-6-phosphate dehydrogenase deficiency may experience hemolytic anemia and should be monitored closely
• Alcohol consumption: Can increase the risk of severe hypoglycemia and should be limited or avoided while taking this medication

Interactions

Several medications and substances can interact with gliclazide:

• Warfarin and blood thinners: Gliclazide may enhance anticoagulant effects, increasing bleeding risk
• Beta-blockers: Can mask symptoms of hypoglycemia and may prolong low blood sugar episodes
• ACE inhibitors: May increase the blood sugar-lowering effects of gliclazide, requiring dose adjustments
• Corticosteroids: Can reduce the effectiveness of gliclazide by raising blood glucose levels
• Rifampin: May decrease gliclazide effectiveness by increasing its metabolism
• Fluconazole and other antifungals: Can increase gliclazide levels in the blood, raising hypoglycemia risk
• NSAIDs: May enhance blood sugar-lowering effects and increase risk of kidney problems
• Alcohol: Significantly increases risk of severe, prolonged hypoglycemia

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosage ranges from 40mg to 320mg daily, usually taken with breakfast or divided into two doses with meals. The starting dose is commonly 40-80mg daily, with gradual increases based on blood glucose response and tolerance. Extended-release formulations may be taken once daily, while immediate-release forms are often divided into two daily doses. Dosage adjustments should always be made under medical supervision, with regular monitoring of blood glucose levels. Individual dosing requirements vary significantly based on factors including kidney function, other medications, and overall diabetes management goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).